Cargando…
Efficacy and safety of oral traditional Chinese patent medicine for chronic cerebral circulation insufficiency patients: A protocol for a systematic review and network meta-analysis
BACKGROUND: Chronic cerebral circulation insufficiency (CCCI) is a common clinical cerebrovascular disease, especially among middle-aged and elderly patients, which seriously endangers their quality of life and physical and mental health. At present, Oral traditional Chinese patent medicine (OTCPM)...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635251/ https://www.ncbi.nlm.nih.gov/pubmed/31277122 http://dx.doi.org/10.1097/MD.0000000000016175 |
_version_ | 1783435842568585216 |
---|---|
author | Xu, Zhongbo Feng, Xin Li, Lin Hu, Ziyi Xiao, Yuan Jin, Guilin Liao, Weimin |
author_facet | Xu, Zhongbo Feng, Xin Li, Lin Hu, Ziyi Xiao, Yuan Jin, Guilin Liao, Weimin |
author_sort | Xu, Zhongbo |
collection | PubMed |
description | BACKGROUND: Chronic cerebral circulation insufficiency (CCCI) is a common clinical cerebrovascular disease, especially among middle-aged and elderly patients, which seriously endangers their quality of life and physical and mental health. At present, Oral traditional Chinese patent medicine (OTCPM) is widely used in the treatment of CCCI in China, but its actual efficacy and safety lack of evidence-based evidence. Therefore, we will screen out the most effective OTCPM through a systematic review and network meta-analysis to provide a reliable theoretical basis for clinical decisions. METHODS: We will search electronic databases to collect relevant RCT studies from inception to October 2019. Those electronic databases include PubMed, Cochrane Library, Web of Science, EMBASE, China Biomedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), Chinese Scientific Journal Database (VIP), and Wan-fang database. Only randomized clinical trials (RCTs) concerned any OTCPM treatments for CCCI will be collected. The included studies will no restrictions on language or publication year. There were no publication year or language for the included literature. Risk bias tools will assess the quality of the included literature. A Bayesian NMA will be performed to combine the direct and indirect comparisons of TCPMs interventions. The surface under the cumulative ranking curve (SUCRA) will be drawn to display the hierarchy of each TCPMs treatment. All statistical analyses will be implemented using R v3.5.2. and GeMTC v1.4.3. We will publish this systematic review in academic journals. Since this literature review will not involve directly contacting patients, ethical approval and informed consent are not required. TRIAL REGISTRATION NUMBER: CRD42019123878. |
format | Online Article Text |
id | pubmed-6635251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-66352512019-08-01 Efficacy and safety of oral traditional Chinese patent medicine for chronic cerebral circulation insufficiency patients: A protocol for a systematic review and network meta-analysis Xu, Zhongbo Feng, Xin Li, Lin Hu, Ziyi Xiao, Yuan Jin, Guilin Liao, Weimin Medicine (Baltimore) Research Article BACKGROUND: Chronic cerebral circulation insufficiency (CCCI) is a common clinical cerebrovascular disease, especially among middle-aged and elderly patients, which seriously endangers their quality of life and physical and mental health. At present, Oral traditional Chinese patent medicine (OTCPM) is widely used in the treatment of CCCI in China, but its actual efficacy and safety lack of evidence-based evidence. Therefore, we will screen out the most effective OTCPM through a systematic review and network meta-analysis to provide a reliable theoretical basis for clinical decisions. METHODS: We will search electronic databases to collect relevant RCT studies from inception to October 2019. Those electronic databases include PubMed, Cochrane Library, Web of Science, EMBASE, China Biomedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), Chinese Scientific Journal Database (VIP), and Wan-fang database. Only randomized clinical trials (RCTs) concerned any OTCPM treatments for CCCI will be collected. The included studies will no restrictions on language or publication year. There were no publication year or language for the included literature. Risk bias tools will assess the quality of the included literature. A Bayesian NMA will be performed to combine the direct and indirect comparisons of TCPMs interventions. The surface under the cumulative ranking curve (SUCRA) will be drawn to display the hierarchy of each TCPMs treatment. All statistical analyses will be implemented using R v3.5.2. and GeMTC v1.4.3. We will publish this systematic review in academic journals. Since this literature review will not involve directly contacting patients, ethical approval and informed consent are not required. TRIAL REGISTRATION NUMBER: CRD42019123878. Wolters Kluwer Health 2019-07-05 /pmc/articles/PMC6635251/ /pubmed/31277122 http://dx.doi.org/10.1097/MD.0000000000016175 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | Research Article Xu, Zhongbo Feng, Xin Li, Lin Hu, Ziyi Xiao, Yuan Jin, Guilin Liao, Weimin Efficacy and safety of oral traditional Chinese patent medicine for chronic cerebral circulation insufficiency patients: A protocol for a systematic review and network meta-analysis |
title | Efficacy and safety of oral traditional Chinese patent medicine for chronic cerebral circulation insufficiency patients: A protocol for a systematic review and network meta-analysis |
title_full | Efficacy and safety of oral traditional Chinese patent medicine for chronic cerebral circulation insufficiency patients: A protocol for a systematic review and network meta-analysis |
title_fullStr | Efficacy and safety of oral traditional Chinese patent medicine for chronic cerebral circulation insufficiency patients: A protocol for a systematic review and network meta-analysis |
title_full_unstemmed | Efficacy and safety of oral traditional Chinese patent medicine for chronic cerebral circulation insufficiency patients: A protocol for a systematic review and network meta-analysis |
title_short | Efficacy and safety of oral traditional Chinese patent medicine for chronic cerebral circulation insufficiency patients: A protocol for a systematic review and network meta-analysis |
title_sort | efficacy and safety of oral traditional chinese patent medicine for chronic cerebral circulation insufficiency patients: a protocol for a systematic review and network meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635251/ https://www.ncbi.nlm.nih.gov/pubmed/31277122 http://dx.doi.org/10.1097/MD.0000000000016175 |
work_keys_str_mv | AT xuzhongbo efficacyandsafetyoforaltraditionalchinesepatentmedicineforchroniccerebralcirculationinsufficiencypatientsaprotocolforasystematicreviewandnetworkmetaanalysis AT fengxin efficacyandsafetyoforaltraditionalchinesepatentmedicineforchroniccerebralcirculationinsufficiencypatientsaprotocolforasystematicreviewandnetworkmetaanalysis AT lilin efficacyandsafetyoforaltraditionalchinesepatentmedicineforchroniccerebralcirculationinsufficiencypatientsaprotocolforasystematicreviewandnetworkmetaanalysis AT huziyi efficacyandsafetyoforaltraditionalchinesepatentmedicineforchroniccerebralcirculationinsufficiencypatientsaprotocolforasystematicreviewandnetworkmetaanalysis AT xiaoyuan efficacyandsafetyoforaltraditionalchinesepatentmedicineforchroniccerebralcirculationinsufficiencypatientsaprotocolforasystematicreviewandnetworkmetaanalysis AT jinguilin efficacyandsafetyoforaltraditionalchinesepatentmedicineforchroniccerebralcirculationinsufficiencypatientsaprotocolforasystematicreviewandnetworkmetaanalysis AT liaoweimin efficacyandsafetyoforaltraditionalchinesepatentmedicineforchroniccerebralcirculationinsufficiencypatientsaprotocolforasystematicreviewandnetworkmetaanalysis |